(Q42984546)

reason for preferred rank

12 November 2017

Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant ?-interferon for chronic non-A, non-B hepatitis (English)

1 reference

22 October 2022

Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant alpha-interferon for chronic non-A, non-B hepatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654240

22 October 2022

1 reference

placebo-controlled trial

1 reference

1 reference

22 October 2022

author name string

M. Omata

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654240

22 October 2022

Y. Ito

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654240

22 October 2022

O. Yokosuka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654240

22 October 2022

F. Imazeki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654240

22 October 2022

M. Tagawa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654240

22 October 2022

S. Takano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654240

22 October 2022

K. Hosoda

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654240

22 October 2022

M. Tada

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654240

22 October 2022

M. Ohto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654240

22 October 2022

K. Ito

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654240

22 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1654240

22 October 2022

publication date

1 September 1991

1 reference

full work available at URL

12 November 2017

http://link.springer.com/content/pdf/10.1007/BF01307512.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF01307512/fulltext.html

22 October 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF01307512

22 October 2022

1 reference

Digestive Diseases and Sciences

22 October 2022

published in

1 reference

12 November 2017

36

1 reference

12 November 2017

9

1 reference

12 November 2017

1217-1222

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01307512

12 November 2017

0 references

cites work

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

12 December 2020

Interferon-induced enzymatic activities and their role in the antiviral state

1 reference

12 December 2020

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

12 December 2020

Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis

1 reference

12 December 2020

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

12 December 2020

Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Comparison with histological changes in chronic hepatitis B.

1 reference

12 December 2020

A classification of chronic hepatitis

1 reference

12 December 2020

Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects

1 reference

12 December 2020

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

1 reference

12 December 2020

Sensitive radioimmuno assay for 2',5'-oligoadenylates using a novel 125I-labeled derivative of 2',5'-triadenylate 5'-triphosphate

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01307512

1 reference

12 November 2017

1 reference